No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs566366340 |
chr6:163235114-163235115 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs373472472 |
chr6:163235154-163235155 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs111431655 |
chr6:163235158-163235159 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs201609837 |
chr6:163235167-163235168 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs375362455 |
chr6:163235168-163235169 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs62428960 |
chr6:163235169-163235170 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs78706312 |
chr6:163235171-163235172 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs544983734 |
chr6:163235174-163235175 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs377178341 |
chr6:163235179-163235180 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs146271153 |
chr6:163235197-163235198 |
Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs138091090 |
chr6:163235202-163235203 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs575481178 |
chr6:163235227-163235228 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs142680257 |
chr6:163235235-163235236 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs376828813 |
chr6:163235239-163235240 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs111927177 |
chr6:163235259-163235260 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs369315812 |
chr6:163235269-163235270 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs560873912 |
chr6:163235278-163235279 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs538821670 |
chr6:163235288-163235289 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs76289683 |
chr6:163235304-163235305 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs200691930 |
chr6:163235322-163235323 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs376896951 |
chr6:163235342-163235343 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs200987111 |
chr6:163235350-163235351 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs199913677 |
chr6:163235351-163235352 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs551735698 |
chr6:163235373-163235374 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs181622640 |
chr6:163235403-163235404 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs187593202 |
chr6:163235429-163235430 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs34399515 |
chr6:163235461-163235462 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs551248920 |
chr6:163235488-163235489 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs190330943 |
chr6:163235489-163235490 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs536829134 |
chr6:163235524-163235525 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs553648022 |
chr6:163235527-163235528 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs12664922 |
chr6:163235542-163235543 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
33 |
rs79014228 |
chr6:163235610-163235611 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs181046889 |
chr6:163235639-163235640 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs575105569 |
chr6:163235653-163235654 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs543807853 |
chr6:163235687-163235688 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs554402838 |
chr6:163235731-163235732 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs71567674 |
chr6:163235800-163235801 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs185305227 |
chr6:163235801-163235802 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs537353464 |
chr6:163235824-163235825 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs116334867 |
chr6:163235828-163235829 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs532350401 |
chr6:163235832-163235833 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs545141418 |
chr6:163235838-163235839 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs189664081 |
chr6:163235839-163235840 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs527346112 |
chr6:163235840-163235841 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs374075830 |
chr6:163235865-163235866 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs551035533 |
chr6:163235876-163235877 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs567956811 |
chr6:163235906-163235907 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs530443618 |
chr6:163235956-163235957 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs182712841 |
chr6:163236025-163236026 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|